trending Market Intelligence /marketintelligence/en/news-insights/trending/aS-tIKq2pRFrdzrcFWsq7A2 content esgSubNav
In This List

Moody's withdraws BioMed ratings


Japan M&A By the Numbers: Q4 2023

Case Study

An Investment Bank Taps S&P's Real Estate Modeling Expertise


FIMA EUROPE 2023: Exploring the Intersection of Data, Governance, and Future Trends in Finance


Private Markets 360° | Episode 8: Powering the Global Private Markets (with Adam Kansler of S&P Global Market Intelligence)

Moody's withdraws BioMed ratings

Moody's withdrew its ratings on , citing its "ownbusiness reasons."

The company's ratings that were withdrawn include its Ba1issuer rating, (P)Ba1 senior unsecured shelf, (P)Ba2 subordinate shelf and(P)Ba2 preferred stock shelf.

Moody's also withdrew BioMed Realty LP's (P)Ba1 seniorunsecured shelf and (P)Ba2 subordinate shelf ratings.

The outlook is negative.

The rating agency in January BioMed after it wastaken out byaffiliates of Blackstone Group LP'sBlackstone Real Estate Partners VIII LP.